Supra-physiological rhGH administration induces gender-related differences in the hypothalamus–pituitary–thyroid (HPT) axis in healthy individuals

Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women

(2013) Catalina Norman et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Somatostatin receptor expression in thyroid disease

(2013) Helen Atkinson et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

The phosphodiesterases type 5 inhibitor tadalafil reduces the activation of the hypothalamus-pituitary-adrenal axis in men during cycle ergometric exercise

(2012) Luigi Di Luigi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Diagnosing Growth Hormone Deficiency in Adults

(2012) Nigel Glynn et al.   International Journal of Endocrinology

Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline

(2011) Mark E. Molitch et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The interaction between growth hormone and the thyroid axis in hypopituitary patients

(2010) Lucy Ann Behan et al.   CLINICAL ENDOCRINOLOGY

Effect of supra-physiological dose administration of rhGH on pituitary-thyroid axis in healthy male athletes

(2010) Paolo Sgrò et al.   REGULATORY PEPTIDES

Growth hormone, IGF-I and insulin and their abuse in sport

(2008) R I G Holt et al.   BRITISH JOURNAL OF PHARMACOLOGY

Supplements and the Endocrine System in Athletes

(2008) Luigi Di Luigi   CLINICS IN SPORTS MEDICINE

The Long-Acting Phosphodiesterase Inhibitor Tadalafil does not Influence Athletes' V·O2max, Aerobic, and Anaerobic Thresholds in Normoxia

(2008) L. Di Luigi et al.   INTERNATIONAL JOURNAL OF SPORTS MEDICINE